July 13, 2021 -- Abcam has opened a new 100,000-sq-ft facility in Waltham, MA, to serve as a hub for its research and development (R&D) and commercial activities in the region.
The facility will more than double Abcam's capacity at its previous site in Cambridge, MA, and will eventually house about 300 employees, according to the company. The new site will increase the company's flexibility, scale, and capacity in R&D, production, distribution, and customer service for biopharma partners and life science researchers.
Abcam provides reagents to support development of diagnostics, vaccines, and potential therapeutics.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
